Table 2.
Lifetime risk for CKD stage 3 or higher by starting age, stratified by sex
| Baseline Age (yr) | Years from Baseline Age | ||||
|---|---|---|---|---|---|
| 5 | 10 | 20 | 30 | 40 | |
| Women | |||||
| 45 | 0.8 (0.3 to 1.3) | 2.0 (1.3 to 2.8) | 7.8 (6.6 to 9.1) | 20.4 (18.4 to 22.3) | 35.8 (32.7 to 38.9) |
| 55 | 2.0 (1.3 to 2.7) | 6.0 (4.9 to 7.1) | 18.9 (17.0 to 20.9) | 34.9 (31.7 to 38.0) | |
| 65 | 5.3 (4.2 to 6.5) | 14.1 (12.3 to 16.0) | 31.6 (28.3 to 34.9) | ||
| 75 | 10.0 (7.8 to 12.2) | 22.2 (18.4 to 26.0) | |||
| 80 | 15.0 (11.0 to 19.0) | 24.9 (19.1 to 30.7) | |||
| Men | |||||
| 45 | 0.2 (0 to 0.5) | 1.4 (0.8 to 2.0) | 4.5 (3.5 to 5.5) | 12.1 (10.4 to 13.8) | 21.3 (18.7 to 23.8) |
| 55 | 1.2 (0.7 to 1.7) | 3.2 (2.3 to 4.1) | 11.1 (9.4 to 12.8) | 20.7 (18.1 to 23.3) | |
| 65 | 2.7 (1.8 to 3.6) | 9.0 (7.3 to 10.7) | 19.8 (17.0 to 22.6) | ||
| 75 | 8.2 (6.0 to 10.3) | 13.9 (10.9 to 17.0) | |||
| 80 | 7.4 (4.5 to 10.4) | 10.4 (6.5 to 14.2) | |||
Cumulative risk is shown as a percentage (95% confidence interval). Lifetime risk estimates are adjusted for competing risk of death. Cumulative risk was not determined for missing cells because of the small number of events.